• Ticker

DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

Akorn, Inc.

NASDAQ:AKRX

$13.70 $0.11 (0.81%)

REAL-TIME: Last trade at

9 Profitable Small Cap Stocks Targeted To Grow

This Month's High-Risk, High-Reward Small Caps

Akorn Beats on Both Top and Bottom Lines

Investing 101: High-Growth Smart-Money Picks Reporting Earnings Next Week

Are Supply Troubles a Biotech Buying Opportunity?

Akorn, Inc. Enters Oversold Territory - Tale of the Tape

High-Risk, High-Reward Small Caps

Investing 101: Undervalued Health Care Stocks Being Bought Up by Hedge Funds

Why Did These Stocks Just Die?

With Revenue Decimated, Is ViroPharma a Buy?

March's Foolish 8 Stocks

The Gory Details of Akorn's Earnings Miss

Akorn, Inc. - Momentum

Zacks Releases Four Powerful ''Buy'' Stocks: BE Aerospace, Yum! Brands, Akorn and H.B. Fuller - Pres

Zacks.com featured expert Kevin Matras highlights: Akorn, Inc., Diana Shipping Inc., Endo Pharmaceut

Zacks #1 Rank Additions for Friday - Tale of the Tape

Wall Street Experts: Deutsche Bank Loves These Stocks Boosted by Insider Buying

Rallying Stocks: Will Small Investors Miss Out on the Rally, Again?

3 Stocks Ready to Roar

Here's Why Akorn's Latest Report Might Worry You

Why Hi-Tech Pharmacal May Be About to Take Off

Against the Herd: If Everyone Else is Selling Stocks, Should You?

Against the Herd: If Everyone Else Is Selling Stocks, Should You?

Investing 101: Rallying Stocks with Institutional and Insider Buying

Investing 101: Rallying Stocks With Institutional and Insider Buying

Market Turmoil: What Should Investors Do Now?

Market Turmoil: What Should Investors Do Now?

The 9 Top Value-Creating Pharmaceutical Companies

Investing 101: Momentum Stocks With Insider Buying

Investing 101: Momentum Stocks with Insider Buying

Investing 101: Rallying Health Care Stocks Being Snapped Up by the Smart Money

Investing 101: Rallying Healthcare Stocks Being Snapped By The Smart Money

Investing 101: Finding Rallying Stocks Still Undervalued to Analyst Estimates

Investing 101: Finding Rallying Stocks Still Undervalued to Analyst Estimates

Generics on the Rise: A Big Threat to Big Pharma?

A Small Cap Company Worth Noting

FDA Approves Generics Of J&J Antibiotic Levaquin

Top Pharma Stocks That Hedge Funds Love

27 Stocks Worth Watching That Hit 52-Week Highs Last Friday

Momentum Ideas: Friday's High Volume Gainers Chased by Big Money Managers

See More Articles...